RecallGuide.ca
    Health productsUpdated Jan 3, 2026SandozOfficial source

    Sandoz-Irbesartan recall in Canada: impurity risk

    Share:

    In plain language

    This recall involves Sandoz Irbesartan 150mg and 300mg tablets sold in Canada. They are being recalled because an impurity was found above acceptable limits. Stop using the product and follow the return steps in the official notice.

    What to do

    • Stop using the product immediately.
    • Check the lot numbers provided in the official notice.
    • Return the product as instructed by your pharmacy or healthcare provider.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Sandoz Irbesartan 150mg Tablet

      Lot: KC7216

    • Sandoz Irbesartan 300mg Tablet

      Lot: KF8326

    Why this matters

    Presence of impurity

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: KC7216, KF8326

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Presence of impurity

    What should consumers do?

    Stop using the product immediately. Check the lot numbers provided in the official notice. Return the product as instructed by your pharmacy or healthcare provider.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Presence of impurity

    When was this product recalled?

    This product was recalled on May 27, 2021.

    Is the Sandoz brand affected by this recall?

    Yes, Sandoz products are affected by this recall. This recall involves Sandoz Irbesartan 150mg and 300mg tablets sold in Canada. They are being recalled because an impurity was found above acceptable limits. Stop using the product and follow the return steps in the official notice.